|
Top 10 Most Popular Articles per Month of Anti-Cancer Agents
in Medicinal Chemistry
2011> | January
| February
| March |
Contents
For the month of January
Updates of mTOR Inhibitors,
2010 Vol 10 Iss.7
H. Zhou, Y. Luo and S. Huang
Editorial [Hot topic: Metal-Containing Drugs
and Novel Coordination Complexes in Therapeutic Anticancer
Applications - Part II], 2010 Vol 10 Iss.5
Guest Editor: Irena Kostova
Emerging Therapeutic Targets and Agents for Glioblastoma
Migrating Cells, 2010 Vol 10 Iss.7
C. Di, A.K. Mattox, S. Harward and C.
Adamson
Combination Therapy with Arsenic Trioxide
for Hematological Malignancies, 2010 Vol 10 Iss.6
S. Takahashi
Editorial [Hot topic:Metal-Containing Drugs and Novel
Coordination Complexes in Therapeutic Anticancer Applications
- Part I], 2010 Vol 10 Iss.4
Guest Editor: Irena Kostova
The Protein Kinase Inhibitor Balanol: Structure-Activity
Relationships and Structure-Based Computational Studies,
2008 Vol 8 Iss.6
V. Pande, M.J. Ramos and F. Gago
Fresh Platinum Complexes with Promising Antitumor
Activity, 2010 Vol 10 Iss.4
X. Wang
Current Status of Thalidomide and CC-5013 in the Treatment
of Metastatic Prostate Cancer, 2009 Vol 9 Iss.10
T.M. Sissung, S. Thordardottir, E.R. Gardner and
W.D. Figg
New Medical Strategies for Midgut Carcinoids,
2010 Vol 10 Iss.3
O. Nilsson, Y. Arvidsson, V. Johanson, E. Forssell-Aronsson
and H. Ahlman
Exploiting Cyclooxygenase-(in)Dependent Properties
of COX-2 Inhibitors for Malignant Glioma Therapy,
2010 Vol 10 Iss.6
A.H. Schönthal
For
the month of February
Updates of mTOR Inhibitors, 2010
Vol 10 Iss.7
H. Zhou, Y. Luo and S. Huang
Targeted Therapies in Metastatic Melanoma: Toward
a Clinical Breakthrough?, 2010 Vol 10 Iss.9
F. Julia, L. Thomas, C. Dumontet and S. Dalle
FK506 Binding Proteins as Targets in Anticancer Therapy,
2010 Vol 10 Iss.9
S. Romano, A.L.D. Pace, A. Sorrentino, R. Bisogni, L.
Sivero and M.F. Romano
Discovery of Allosteric Inhibitors of Kinesin Spindle
Protein (KSP) for the Treatment of Taxane-Refractory Cancer:
MK-0731 and Analogs, 2010 Vol 10 Iss.9
C.D. Cox and R.M. Garbaccio
Editorial [Hot topic:Metal-Containing Drugs and Novel
Coordination Complexes in Therapeutic Anticancer Applications
- Part I], 2010 Vol 10 Iss.4
Guest Editor: Irena Kostova
Overcoming Resistance of Glioblastoma to Conventional
Cytotoxic Therapies by the Addition of PARP Inhibitors,
2010 Vol 10 Iss.7
A.J. Chalmers
The Interactions of Anti-Cancer Drugs Approved in
the Last Decade in the United States with Membrane Transporters,
2010 Vol 10 Iss.8
L. Jain, S. Abraham and S.S. Shord
Pomegranate Extract, A Prooxidant with Antiproliferative
and Proapoptotic Activities Preferentially Towards Carcinoma
Cells, 2010 Vol 10 Iss.8
J.H. Weisburg, A.G. Schuck, M.S. Silverman, C.G. Ovits-Levy,
L.J. Solodokin, H.L. Zuckerbraun and H. Babich
Pharmacogenetics of Drug Metabolizing Enzymes and
Transporters: Effects on Pharmacokinetics and Pharmacodynamics
of Anticancer Agents, 2010 Vol 10
Iss.8
N.H. Lee
MRI Contrast Agents: Current Status and Future Perspectives
G.J. Strijkers, W.J.M. Mulder, G.A.F. van Tilborg and
K. Nicolay
For
the month of March
Discovery of Allosteric Inhibitors of Kinesin Spindle
Protein (KSP) for the Treatment of Taxane-Refractory Cancer:
MK-0731 and Analogs, 2010 Vol 10 Iss.9
C.D. Cox and R.M. Garbaccio
Cilengitide: The First Anti-Angiogenic Small Molecule
Drug Candidate. Design, Synthesis and Clinical Evaluation,
2010 Vol 10 Iss.10
Carlos Mas-Moruno, Florian Rechenmacher and
Horst Kessler
Editorial [Hot Topic: Rising of Phosphatases as Targets
of Cancer Treatment (Guest Editor: Petr Heneberg)],
2011 Vol 11 Iss.1
Guest Editor: Petr Heneberg
Evolving Therapies and FAK Inhibitors for the Treatment
of Cancer, 2010 Vol 10 Iss.10
Kelli Bullard Dunn, Melissa Heffler and Vita
M. Golubovskaya
Emerging Therapeutic Targets and Agents for Glioblastoma
Migrating Cells, 2010 Vol 10 Iss.7
C. Di, A.K. Mattox, S. Harward and C.
Adamson
FAK and Interacting Proteins as Therapeutic Targets
in Pancreatic Cancer, 2010 Vol 10
Iss.10
Deniz A. Ucar and Steven N. Hochwald
Updates of mTOR Inhibitors, 2010
Vol 10 Iss.7
H. Zhou, Y. Luo and S. Huang
Focal Adhesion Kinase as a Therapeutic Target of Bortezomib,
2010 Vol 10 Iss.10
Bor-Sheng Ko, Tzu-Ching Chang and Jun-Yang Liou
New Medical Strategies for Midgut Carcinoids,
2010 Vol 10 Iss.3
O. Nilsson, Y. Arvidsson, V. Johanson, E. Forssell-Aronsson
and H. Ahlman
Targeted Therapies in Metastatic Melanoma: Toward
a Clinical Breakthrough?, 2010 Vol 10 Iss.9
F. Julia, L. Thomas, C. Dumontet and S. Dalle
|
